Diabetic Ketoacidosis
- Monitoring and evaluating the impact of the guideline.
The following are three performance measures or indicators for implementing this adapted CPG for DKA in children:
1.Adherence to DKA Guidelines
· Numerator: Number of children with DKA who received treatment as per guideline recommendations.
· Denominator: Total number of children diagnosed with diabetes
· Data Source: Hospital or clinic patient records.
2. Duration of Hospital Stay
· Numerator: Total number of hospital stay days for children with DKA
· Denominator: Total number of children admitted with type 1 diabetes
· Data Source: Hospital admission and discharge records.
3. Rate of Readmission
· Numerator: Number of children readmitted with symptoms of DKA within a certain period (e.g., 30 days) after discharge.
· Denominator: Total number of children initially admitted with diabetes
· Data Source: Hospital readmission records.
These key performance indicators are designed to measure the effectiveness and adherence to the guidelines, the efficiency of the treatment in terms of resource utilization (hospital stay), and the success of the treatment in preventing further complications (readmissions).
➡️Updating of the guideline
The EPG Endocrin GAG has decided to conduct the next review of this adapted CPG for updates after five years. This should be carried out in 2029 after checking for updates in the source CPGs, consultation of expert opinion on the changes needed for updating according to the newest evidence and recommendations published in this area and the clinical audit and feedback from implementation efforts in the aforementioned local healthcare settings except if any breakthrough evidence- based recommendations are published before that date. The process will be guided by the Checklist for the Reporting of Updated Guidelines (CheckUp) Tool that is freely provided by the AGREE Enterprise and by the Reporting Items for Practice Guidelines in Healthcare (RIGHT) extension for adapted guidelines RIGHT-Ad@pt Checklist.